Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026)

Johnson & Johnson (JNJ) posted Total Current Liabilities of $57.7 billion for Q1 2026, up 6.63% sequentially from $54.1 billion in Q4 2025, and up 1.43% YoY from $56.9 billion in Q1 2025.

Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Total Current Liabilities data on file, last reported at $57.7 billion in Q1 2026.

  • Quarterly Total Current Liabilities rose 1.43% year-over-year to $57.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.7 billion (up 1.43% YoY) and the FY2025 annual result came in at $54.1 billion, up 7.56% from the prior year.
  • Total Current Liabilities rose to $57.7 billion in Q1 2026 per JNJ's latest filing, from $54.1 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $60.4 billion in Q2 2023, with the low at $43.4 billion in Q2 2022.
  • Average Total Current Liabilities over 5 years is $51.0 billion, with a median of $51.3 billion recorded in 2024.
  • Year-over-year, Total Current Liabilities soared 39.14% in 2023 and decreased 19.29% in 2024.
  • Johnson & Johnson's Total Current Liabilities stood at $45.5 billion in 2022, then increased by 1.62% to $46.3 billion in 2023, then rose by 8.73% to $50.3 billion in 2024, then grew by 7.56% to $54.1 billion in 2025, then increased by 6.63% to $57.7 billion in 2026.
  • Business Quant data shows JNJ's Total Current Liabilities at $57.7 billion in Q1 2026, $54.1 billion in Q4 2025, and $50.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 36.63 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 57.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 42.10 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -32.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 26.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 9.48 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 34.35 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 3.00 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 57.72 Bn
Dec 28, 2025 54.13 Bn
Sep 28, 2025 50.87 Bn
Jun 29, 2025 54.18 Bn
Mar 30, 2025 56.90 Bn
Dec 29, 2024 50.32 Bn
Sep 29, 2024 51.76 Bn
Jun 30, 2024 53.93 Bn
Mar 31, 2024 48.73 Bn
Dec 31, 2023 46.28 Bn
Oct 1, 2023 44.37 Bn
Jul 2, 2023 54.17 Bn
Apr 2, 2023 60.37 Bn
Jan 1, 2023 55.80 Bn
Oct 2, 2022 45.54 Bn
Jul 3, 2022 44.82 Bn
Apr 3, 2022 43.39 Bn
Jan 2, 2022 45.23 Bn
Oct 3, 2021 44.56 Bn
Jul 4, 2021 38.72 Bn